tradmap

NAII NATURAL ALTERNATIVES INTERNATIONAL INC

Price unavailable

No recent data for NAII. Our end-of-day feed has carried no price for this security since 2026-09-02, and we found no SEC delisting or deregistration filing that would explain it — so this reflects the coverage of our data source. The security may still be trading, and quotes may be available elsewhere. Company filings and reported financials on this page are unaffected.

Updated

Healthcare · Medicinal Chemicals & Botanical Products

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) is a healthcare company in the Medicinal Chemicals & Botanical Products industry, with a market capitalization of $12 million. Price data for NAII is unavailable — our feed has carried no quote since 2026-09-02. Net profit margin is -10.1%, below the peer median of -8.5%. Revenue declined 74.8% year over year.

Market Cap
$12M
Shares Out
5.8M
EPS (TTM)
$-2.12
P/E Ratio
P/S Ratio
0.09
P/B Ratio
0.20
Dividend / Share
Dividend Yield
52-Week High
$4.96
52-Week Low
$1.87
Volume
1,599
Avg Vol (3m)
826.524

Chart hidden: no price data for NAII since 2026-09-02. Company filings and financials below are current.

Financials

Revenue
$142M
Net Income
$-14M
Gross Margin
7.6%
Operating Margin
-5.3%
Net Margin
-10.1%
Return on Equity
-22.8%
Return on Assets
-9.3%
Current Ratio
1.64
Debt / Equity
0.00
Revenue Growth (YoY)
-74.8%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2022 $-0.41 2023-05-15
Q3 2026 $-1.19 2026-05-19
Q2 2026 $-0.47 2026-02-13
Q1 2026 $-0.05 2025-11-12
FY 2025 $-2.28 2025-09-23
Q3 2026 $-1.07 2026-05-19

Full earnings history →

Medicinal Chemicals & Botanical Products peers

NAII vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap. Updated

P/S vs peers
0.09 / 0.29 med
-70% discount
Net margin vs peers
-10.1% / -8.5% med
below median
1–14 of 14
DFTXDefinium Therapeutics, Inc.$5.1B-14.43-2.40%
TRLVTrulieve Cannabis Corp.$2.3B-4.862.03-41.8%+2.56%
TLRYTilray Brands$616M-5.070.67-13.3%+0.11%
USNAUSANA HEALTH SCIENCES INC$267M-12.030.29-2.4%-1.30%
NAGENiagen Bioscience, Inc.$246M15.411.9112.4%-1.89%
FTLFFITLIFE BRANDS, INC.$93M14.860.916.2%-3.10%
BTMDbiote Corp.$46M7.820.253.2%-9.91%
MTEXMANNATECH INC$14M-1.900.13-6.9%-2.93%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC$12M-0.860.09-10.1%-0.47%
SNYRSynergy CHC Corp.$2M-0.100.06-57.0%-2.03%
CRONCronos Group39.1%+0.46%
CGCCanopy Growth-80.4%+0.27%
GLASGlass House Brands Inc.-16.3%+3.61%
IMCCIM Cannabis Corp.-27.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.